SleepDNA: startup focused on early recognition and treatment of sleep diseases

Big Data driven, patient oriented mHealth startup focused on early recognition and treatment of sleep diseases.

About us:
We’ve developed a unique and innovative platform that provides an individualized sleep solution for each sleep struggler. We aim to decipher the puzzle of sleeplessness. SleepASAP interacts with sleep strugglers and sleep experts to learn, understand and design lasting solutions for all forms of sleeping problems.

SleepDNA

Unlike any other Digital Health Solutions, through our innovative platform, the customer receives a preliminary diagnosis of SleepDNA – a combination of personality + sleep symptoms. Based on SleepDNA, our system generates a menu of methods that have helped people with same situation in the past.
We also connect customers with the best solution and experts in that solution, tailored and personalized.

Market opportunity:
Sleep deprivation affects 45% of the world, and this number is growing, with 70-90 million sleep strugglers in the US alone. Direct annual costs in the US are estimated at $13.9 billion, with an additional indirect annual cost (lost work productivity, insomnia-related health issues and work accidents, etc.) of $69 billion. (* CDC – Center for Diseases Control and prevention).

Key Differentiator:
Unlike any other Digital Health Solutions, through our innovative platform, the customer receives a preliminary diagnosis of SleepDNA – a combination of personality + sleep symptoms. Based on SleepDNA, our system generates a menu of methods that have helped people with same situation in the past.
We also connect customers with the best solution and experts in that solution, tailored and personalized.

Press:
http://www.timesofisrael.com/israeli-tech-cracks-sleep-dna-to-beat-insomnia/
http://www.israel21c.org/waze-for-the-sleep-deprived/
https://vanwinkles.com/the-upcoming-sleepasap-app-will-help-you-sleep-through-crowdsourcing?utm_campaign=SF&utm_source=facebook&utm_medium=social

Highlights
1. No FDA needed
2. Paid customers
3. Established Marketing in US
4. A very strong and experienced team
5. Our data sets act as a predictors for cardiovascular & metabolic diseases

Source: icnw